navigation icon navigation icon hover

Amgen, Dublin, Ireland

CASE STUDY

A €92m biotechnology production building to create increased capacity for the sterile fill / finish of existing products, with active biopharmaceutical ingredients supplied from Amgen’s biotechnology manufacturing plants overseas.

The scheme will include capacity for vial filling and the packaging of sterile liquid products.

The project required the construction of the PM3 production building, which is a two-storey building with a penthouse plant room, located in the south eastern part of the plant, and a single-storey extension to the warehouse. The warehouse extension was built in two phases. Two single-storey link buildings link the PM3 building and the extended warehouse to existing buildings in the plant. The project included alterations and expansion of the permanent car park to increase the capacity by 111 spaces. Minor modifications of the exterior of the PM2 building and the existing warehouse were required to facilitate the new buildings.

The PM3 project resulted in increased capacity for the sterile fill/finish of existing products. The active biopharmaceutical ingredients for the products come from Amgen’s biotechnology manufacturing plants overseas. In addition, there is capacity for vial filling and packaging sterile liquid products. The PM3 development resulted in Amgen Dún Laoghaire becoming a key location within the global Amgen organisation.

Summary of Scope of Works:

We acted as Management Contractor for the project, including taking on the role of PSCS.

All works, including the following key packages were direct contracts to Sisk:

  • Enabling works
  • Mechanical
  • Electrical
  • Builders Work
  • Floor Finishes
  • Steel and Platforms
  • Cleanrooms
Size:

New PM3 Production Building: 8,641m²

Extension to existing warehouse: 3,057m